Radiation Resistance of Breast Cancer Stem Cells: Understanding the Clinical Framework

Overview

Journal J Mammary Gland Biol Neoplasia

Date 2009 Mar 3

PMID 19252973

Citations 24

Authors

Bisrat G Debeb

Wei Xu

Wendy A Woodward

Affiliations

Soon will be listed here.

Abstract

Meta-analyses of tens of thousands of women treated with radiation as a component of their breast cancer treatment have shown that radiation improves overall survival from breast cancer in women with early stage and advanced disease. However, data suggest that breast cancer stem/progenitor cells can be enriched after radiation and that breast cancer stem/progenitor clonogens are particularly resistant to radiation. Potentially resistant breast cancer stem/progenitor populations appear to be over-represented in estrogen receptor negative breast cancer and indeed, clinically these cancers are more resistant to radiation than estrogen receptor positive breast cancers. Emerging pre-clinical data suggest that targeting cancer stem/progenitor survival pathways may lead to effective radiosensitization in subgroups of patients with resistant disease. Herein, preclinical studies are reviewed in the context of the clinical framework.

Citing Articles

GammaTile® (GT) as a brachytherapy platform for rapidly growing brain metastasis.

Dharnipragada R, Ferreira C, Shah R, Reynolds M, Dusenbery K, Chen C Neurooncol Adv. 2023; 5(1):vdad062.

PMID: 37324216 PMC: 10263112. DOI: 10.1093/noajnl/vdad062.

Raman Spectroscopy Revealed Cell Passage-Dependent Distinct Biochemical Alterations in Radiation-Resistant Breast Cancer Cells.

Rauniyar S, Pansare K, Sharda A, Singh S, Saha P, Chilakapati M ACS Omega. 2023; 8(6):5522-5532.

PMID: 36816694 PMC: 9933476. DOI: 10.1021/acsomega.2c06787.

Counteracting Chemoresistance with Metformin in Breast Cancers: Targeting Cancer Stem Cells.

Samuel S, Varghese E, Koklesova L, Liskova A, Kubatka P, Busselberg D Cancers (Basel). 2020; 12(9).

PMID: 32883003 PMC: 7565921. DOI: 10.3390/cancers12092482.

Inhibitor of DNA binding 1 (Id1) mediates stemness of colorectal cancer cells through the Id1-c-Myc-PLAC8 axis via the Wnt/β-catenin and Shh signaling pathways.

Sun Y, Lai X, Yu Y, Li J, Cao L, Lin W Cancer Manag Res. 2019; 11:6855-6869.

PMID: 31440083 PMC: 6664424. DOI: 10.2147/CMAR.S207167.

MicroRNAs, Hypoxia and the Stem-Like State as Contributors to Cancer Aggressiveness.

Wanjiku Macharia L, Wanjiru C, Mureithi M, Pereira C, Ferrer V, Moura-Neto V Front Genet. 2019; 10:125.

PMID: 30842790 PMC: 6391339. DOI: 10.3389/fgene.2019.00125.

References

Zhang M, Behbod F, Atkinson R, Landis M, Kittrell F, Edwards D . Identification of tumor-initiating cells in a p53-null mouse model of breast cancer. Cancer Res. 2008; 68(12):4674-82. PMC: 2459340. DOI: 10.1158/0008-5472.CAN-07-6353. View

Kyndi M, Sorensen F, Knudsen H, Overgaard M, Nielsen H, Overgaard J . Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group. J Clin Oncol. 2008; 26(9):1419-26. DOI: 10.1200/JCO.2007.14.5565. View

Jang Y, Sharkis S . A low level of reactive oxygen species selects for primitive hematopoietic stem cells that may reside in the low-oxygenic niche. Blood. 2007; 110(8):3056-63. PMC: 2018677. DOI: 10.1182/blood-2007-05-087759. View

Al-Hajj M, Wicha M, Benito-Hernandez A, Morrison S, Clarke M . Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A. 2003; 100(7):3983-8. PMC: 153034. DOI: 10.1073/pnas.0530291100. View

Chen C, Liu Y, Liu R, Ikenoue T, Guan K, Liu Y . TSC-mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species. J Exp Med. 2008; 205(10):2397-408. PMC: 2556783. DOI: 10.1084/jem.20081297. View

Brown J, Wouters B . Apoptosis, p53, and tumor cell sensitivity to anticancer agents. Cancer Res. 1999; 59(7):1391-9. View

Ginestier C, Hur M, Charafe-Jauffret E, Monville F, Dutcher J, Brown M . ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell. 2008; 1(5):555-67. PMC: 2423808. DOI: 10.1016/j.stem.2007.08.014. View

Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans V . Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005; 366(9503):2087-106. DOI: 10.1016/S0140-6736(05)67887-7. View

Smith G, Medina D . A morphologically distinct candidate for an epithelial stem cell in mouse mammary gland. J Cell Sci. 1988; 90 ( Pt 1):173-83. DOI: 10.1242/jcs.90.1.173. View

10.

Munshi A, Hobbs M, Meyn R . Clonogenic cell survival assay. Methods Mol Med. 2005; 110:21-8. DOI: 10.1385/1-59259-869-2:021. View

11.

Xiao Y, Ye Y, Yearsley K, Jones S, Barsky S . The lymphovascular embolus of inflammatory breast cancer expresses a stem cell-like phenotype. Am J Pathol. 2008; 173(2):561-74. PMC: 2475792. DOI: 10.2353/ajpath.2008.071214. View

12.

Woodward W, Chen M, Behbod F, Alfaro M, Buchholz T, Rosen J . WNT/beta-catenin mediates radiation resistance of mouse mammary progenitor cells. Proc Natl Acad Sci U S A. 2007; 104(2):618-23. PMC: 1766434. DOI: 10.1073/pnas.0606599104. View

13.

Dontu G, Abdallah W, Foley J, Jackson K, Clarke M, Kawamura M . In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev. 2003; 17(10):1253-70. PMC: 196056. DOI: 10.1101/gad.1061803. View

14.

Shin B, Lee Y, Lee J, Kim H, Lee J, Cho S . Breast carcinomas expressing basal markers have poor clinical outcome regardless of estrogen receptor status. Oncol Rep. 2008; 19(3):617-25. View

15.

Bao S, Wu Q, McLendon R, Hao Y, Shi Q, Hjelmeland A . Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 2006; 444(7120):756-60. DOI: 10.1038/nature05236. View

16.

Wadasadawala T, Gupta S, Bagul V, Patil N . Brain metastases from breast cancer: management approach. J Cancer Res Ther. 2007; 3(3):157-65. DOI: 10.4103/0973-1482.37409. View

17.

Carlson R, McCormick B . Update: NCCN breast cancer Clinical Practice Guidelines. J Natl Compr Canc Netw. 2005; 3 Suppl 1:S7-11. View

18.

Chen M, Woodward W, Behbod F, Peddibhotla S, Alfaro M, Buchholz T . Wnt/beta-catenin mediates radiation resistance of Sca1+ progenitors in an immortalized mammary gland cell line. J Cell Sci. 2007; 120(Pt 3):468-77. DOI: 10.1242/jcs.03348. View

19.

Phillips T, McBride W, Pajonk F . The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation. J Natl Cancer Inst. 2006; 98(24):1777-85. DOI: 10.1093/jnci/djj495. View

20.

. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. Lancet. 2000; 355(9217):1757-70. View